Warburton Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
1,006
-243
-19% -$56.6K 0.1% 58
2026
Q1
$301K Buy
1,249
+192
+18% +$44.7K 0.15% 41
2025
Q4
$218K Buy
+1,057
New +$209K 0.12% 54

Other funds holding JNJ

Warburton Capital Management's JNJ Position: Q2 2026 in Review

Warburton Capital Management reduced its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, selling an estimated $56.6K and leaving 1,006 shares worth $255K. The position accounts for 0.1% of the portfolio, ranked #58.

Warburton Capital Management first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $301K in Q1 2026. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Warburton Capital Management held 1,006 shares of Johnson & Johnson worth $255K as of Q2 2026.
  • Warburton Capital Management sold 243 Johnson & Johnson shares in Q2 2026, an estimated $56.6K.
  • Johnson & Johnson made up 0.1% of Warburton Capital Management's portfolio in Q2 2026, its #58 holding.
  • Warburton Capital Management first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Warburton Capital Management's Johnson & Johnson position peaked at $301K in Q1 2026.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Warburton Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.